We use cookies to ensure that the website works as intended and to collect statistics on its use so that we can improve your web site experience.

×

New Study: Krill Oil Significantly Reduces Major Cardiovascular Risk Factors

A ‘game-changer’ within heart health, says researcher. Krill oil significantly reduces triglyceride levels in the blood - an...

Aker BioMarine appoints SVP Investor Relations

Aker BioMarine ASA is pleased to announce that Carl Christian Bachke has been appointed SVP Investor Relations effective...

Aker BioMarine appoints Douglas C. Hicks as SVP, Business Development & Strategy

Aker BioMarine, the global biotech innovator and world-leading supplier of krill, announces the appointment of biotechnology...

Aker BioMarine lists on Oslo Børs

Euronext today congratulates Aker BioMarine on its transfer from Euronext Growth to Oslo Børs (ticker code: AKBM).

Aker BioMarine commits to industry-leading emissions-free operations in Antarctica

Aker BioMarine launches its ambitious sustainability goals towards 2030.

Fourth quarter 2020: Promising new product launches and adjusted EBITDA growth of 2.5x YoY

Aker BioMarine today announces its results for the fourth quarter 2020.

Aker BioMarine agreement for distribution of the QRILL PAWS - World Arctic Series

Lisa Miller to Join as New Communication Director in the U.S.

Aker BioMarine has become one of Uruguay’s top exporters